Why Aclarion (ACON) Shares Are Skyrocketing

Aclarion Inc ACON shares are trading higher by 114% to $7.09 during Monday’s session after the company announced it signed a commercial deal with Scripps Health to expand Nociscan for spine care.

What To Know: Aclarion has entered a commercial agreement with Scripps Health in San Diego. This partnership will introduce Aclarion's Nociscan technology to Scripps Green and the broader Scripps Health network, the region's largest healthcare system.

The company says now, with the technology available locally, more patients and physicians will benefit from its advanced diagnostics. Scripps Health, a nonprofit system with five hospitals and 19 outpatient facilities, meanwhile serves 500,000 patients annually.

Aclarion's Chief Strategy Officer, Ryan Bond, emphasized the significance of the collaboration, with the company highlighting expanded patient access and ongoing clinical research.

Read Also: Tesla Rebounds While Tariffs Weigh On Manufacturing: What’s Driving Markets Monday?

How To Buy ACON Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Aclarion’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, ACON has a 52-week high of $231.15 and a 52-week low of $2.43.